类风湿性关节炎和功能下降的疾病活性:一项大型前性注册研究
Sho Fukui1,2,3, Wolfgang C Winkelmayer4, Sara K Tedeschi5
1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA sfukui@bwh.harvard.edu dsolomon@bwh.harvard.edu.
Annals of the rheumatic diseases
|August 21, 2024
概括
较高的类风湿性关节炎 (RA) 疾病活性加速功能下降. 保持低的RA活性对于保持脏健康和预防慢性病 (CKD) 进展至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 临床流行病学 临床流行病学
背景情况:
- 慢性病 (CKD) 是患有类风湿性关节炎 (RA) 的患者经常出现的并发症.
- RA 疾病活动对功能的长期影响尚未完全阐明.
研究的目的:
- 调查纵向类风湿性关节炎疾病活动与长期功能之间的关联.
- 根据RA疾病活动水平,评估患慢性病 (CKD) G3a和G3b阶段的风险.
主要方法:
- 在美国 (2001-2022) 分析一个多中心的未来RA注册表.
- 暴露:时间平均临床疾病活动指数 (TA-CDAI) 分类.
- 结果:纵向估计的淋巴细胞过率 (eGFR) 变化和CKD G3a/G3b阶段的发病率,经过对共变量进行调整.
主要成果:
- 与缓解相比,较高的RA疾病活性与较快的年度eGFR下降相关.
- 患者中等和高的RA疾病活动显示显著增加了调整后的危险比率发展CKD阶段G3a和G3b.
- 这项研究包括31,129名患者,随访时间超过146,000人年.
结论:
- 较高的类风湿性关节炎疾病活性与加速的功能衰退和临床显著功能障碍的更高风险有关.
- 研究结果表明,管理RA疾病活动可能是维护RA患者脏健康的关键策略.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Antihypertensive Drugs: Direct Renin Inhibitors
512
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
512
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352


